A Double-Blind, Placebo-Controlled Study of Fermented Deglycyrrhizinated Licorice Extract

PHASE2CompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

January 10, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

August 15, 2024

Conditions
Diabetic Polyneuropathy
Interventions
DRUG

Fermented Deglycyrrhizinated Licorice

Oral capsules containing 500 mg of fermented deglycyrrhizinated licorice root extract standardized to 2500 IU/gm of α-amylase enzyme and naturally occurring flavonoids and acid-lipase. Administered twice daily (1000 mg/day).

DIETARY_SUPPLEMENT

Non-fermented Deglycyrrhizinated Licorice

500 mg non-fermented deglycyrrhizinated licorice root extract capsules, matching FDGL in appearance, color, weight, and excipients. Administered twice daily.

Trial Locations (1)

11651

Al-Azhar University, Cairo

All Listed Sponsors
lead

Helwan University

OTHER